Skip to content

MRI/US fusion and three-dimensional reconstruction guided prostate biopsy in early diagnosis of prostate cancer research

MRI/US fusion and three-dimensional reconstruction guided prostate biopsy in early diagnosis of prostate cancer research

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-16008583
Enrollment
Unknown
Registered
2016-06-02
Start date
2016-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

Gold Standard:
Index test:

Sponsors

The 307th Hospital of Military Chinese People's
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. DRE detected prostatic nodules (PSA is normal or PSA<10ng/ml); 2. Ultrasound B detected prostatic hypoechoic nodule or other imageological examination detected abnormal signal; 3. The level of PSA increased: whether DRE and TURS is normal or not;PSA4-10ng/ml;f/tPSA or PSAD is abnormal; 4. Less than 65 years old.

Exclusion criteria

Exclusion criteria: 1. Patients diagnosed with prostate cancer definitely; 2. Patients with acute prostatitis; 3. Patients with the level of PSA>10ng/ml; 4. Patients taking anticoagulant medicine and withdrawal the drug within one week. 5. Patients with severe osteoarticular diseases can not take lithotomy position; 6. Patients with severe cardiopulmonary insufficiency; 7. Sensitivity to the anesthetic; 8. Infection;pyretogenesis stage;hypertensive crisis;cardiac functional decompensatory;sereve hemorrhagic disease;unstable stage of diabetes; 9. Older than the age of 65.

Design outcomes

Primary

MeasureTime frame
volume of prostaste;TPSA;FPSA;number of the cores;histopathology of biopsy;

Countries

China

Contacts

Public ContactHaixing Mai

The 307th Hospital of Military Chinese People's

maimark24@hotmail.com+86 010 66947325

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026